SUBSCRIBE
SUBSCRIBE
News   Policy

Insmed Incorporated to Discuss Litigation Settlement with Tercica, Inc.

March 7, 2007 | 
1 min read
RICHMOND, Va.--(BUSINESS WIRE)--Insmed (NASDAQ:INSM) announced that it will host a conference call on Wednesday, March 7 at 11:00 a.m. (ET) to discuss the litigation settlement with Genentech and Tercica, and other business details.
Events Legal
Insmed Incorporated
MORE ON THIS TOPIC
Abstract blue and purple DNA molecule helix and brain. Genetic biotechnology engineering concept. Low poly style design. Geometric background. Wireframe light graphic connection structure. Vector
ALS
QurAlis’ Phase 2 data bolster case for genetic approach to sporadic ALS
May 5, 2026
 · 
4 min read
 · 
Heather McKenzie
Recovering losses, effective economic measures to help alleviate inflation or economic crisis resulting in the collapse of the business economy or stock market, helping hands to catch gold coins rolling down a tilted cliff
Patents
Pfizer settles with generic drugmakers to protect blockbuster drug until 2031
April 29, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Panoramic view of San Diego skyline with clear blue sky and calm ocean waters.
Cancer
AACR 2026: Combo therapies by Moderna, Marengo show promise in skin, breast cancer
April 28, 2026
 · 
5 min read
 · 
Andrea Park
man pulling each of the opposite ends of a rope in black and white, on a blue background with some blank space on top
Pancreatic cancer
Revolution levels legal threat on Erasca as pancreatic cancer rivalry heats up
April 28, 2026
 · 
3 min read
 · 
Tristan Manalac